Manufacturer or GPO Program year 2019 Source: CMS Open Payments

COMSORT, Inc

MD, United States

CMS manufacturer 100000000055

Open in the dashboard

General payments

$142,050

1,359 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2019, COMSORT, Inc reported paying $142,050 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $142,050 1,359

Breakdown

Top recipients General payments · program year 2019
  1. Karl Dsilva Hematology & Oncology · Peabody, MA $250 2 payments
  2. Nathan Denell Family Medicine · Lincoln, NE $250 2 payments
  3. Kin Lam Internal Medicine · New York, NY $250 2 payments
  4. Stephen Hall Family Medicine · Pullman, WA $250 2 payments
  5. Steven Rademacher Infectious Disease · Lincoln, NE $200 2 payments
  6. Ralph Nader Cardiovascular Disease · Coral Gables, FL $150 1 payment
  7. Aristides Estrada Internal Medicine · Mine Hill, NJ $150 1 payment
  8. Jayini Thakker Oral & Maxillofacial Surgery · Loma Linda, CA $150 1 payment
  9. George Resnevic Dentist, General Practice · Chepachet, RI $150 1 payment
  10. Douglas Mattingly Family Medicine · Louisville, KY $150 1 payment
Products the payments named General payments · program year 2019
  1. Bridion Neuroscience $67,700 47% · 677 recipients
  2. Keytruda Oncology $33,350 23% · 328 recipients
  3. Sivextro Infectious Disease $20,600 14% · 206 recipients
  4. Gardasil Vaccine $12,300 8% · 82 recipients
  5. Pneumovax 23 Vaccine $8,100 6% · 64 recipients

The top 5 of 6 products; each share is of this company’s general payments naming a product in 2019. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2019
  1. Anesthesiology $61,400 44% · 614 practitioners
  2. Urology $14,500 10% · 145 practitioners
  3. Hematology & Oncology Internal Medicine $14,050 10% · 138 practitioners
  4. Family Medicine $9,350 7% · 71 practitioners
  5. Infectious Disease Internal Medicine $5,900 4% · 57 practitioners

The top 5 of 50 specialties; each share is of this company’s general payments to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $17,700 12% · 171 recipients
  2. New York $13,400 9% · 130 recipients
  3. Texas $10,350 7% · 100 recipients
  4. Pennsylvania $9,150 6% · 87 recipients
  5. Florida $7,350 5% · 68 recipients

The top 5 of 50 states; each share is of this company’s general payments in 2019 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program year 2019
  1. Consulting Fee $142,050 1,359 payments
1,359 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record